000			02412na a2200241 4500
999			_c5819 _d5819
003			PC5819
005			20190730094705.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aGuerra Tapia, Aurora _91360 _eDermatología
245	0	0	_aValidation of the Spanish Acne Severity Scale (Escala de Gravedad del Acné Española--EGAE). _h[artículo]
260			_bEuropean Journal of Dermatology, _c2013
300			_a23(2):233-40.
500			_aFormato Vancouver: Puig L, Guerra-Tapia A, Conejo-Mir J, Toribio J, Berasategui C, Zsolt I. Validation of the Spanish Acne Severity Scale (Escala de Gravedad del Acné Española--EGAE). Eur J Dermatol. 2013 Apr 1;23(2):233-40.
501			_aPMID: 23608147
504			_aContiene 27 referencias
520			_aBackground: Several acne grading systems have been described, but consensus is lacking on which shows superiority. A standardized system would facilitate therapeutic decisions and the analysis of clinical trial data. Objective: To assess the feasibility, reliability, validity and sensitivity to change of the Spanish Acne Severity Scale (EGAE). Materials & Methods: A Spanish, multicentre, prospective, observational study was performed in patients with facial, back or chest acne assessed using EGAE, Leeds Revised Acne Grading system (LRAG) and lesion count. Clinicians answered 4 questions regarding EGAE use and time employed. Patients were evaluated at baseline and after 5 1 weeks. Four additional blinded observers, all dermatologists, evaluated patients' pictures using EGAE and LRAG. Results: In total, 349 acne locations were assessed in 328 patients. Of the dermatologists, 95.6% (CI: 92.9-97.5%) reported that EGAE was easy to use, and 75% used it in <= 3 minutes. Interobserver reliability of the EGAE scale was shown by a Kendall's W of 0.773 (p<0.001). EGAE and LRAG scales showed a high correlation (Spearman's correlation >0.85; p<0.001). EGAE mean score in treatment-compliant patients was significantly lower at follow-up than at baseline (2.14 vs. 1.57, p<0.001, Cohen's d = 0.35).The pre-post-treatment difference in EGAE mean score in non-compliant patients was not significant (1.44 vs. 1.32, p<0.102) and Cohen's d was lower (0.19) than in compliant patients. Conclusion: The use of EGAE to evaluate acne grade in daily clinical dermatological practice in Spanish centres has shown feasibility, high interobserver reliability, concurrent validity and sensitivity to detect treatment effects.
710			_9145 _aServicio de Dermatología Médico-Quirúrgica y Venereología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/5/pc5819.pdf _ySolicitar documento
942			_n0 _2ddc _cART